… conventional haematologic remission and … fluorescence in situ hydridization method to
detect double BCR-ABL fusion and monitor response to therapy in chronic myeloid leukaemia. …

… (determined using fluorescence in situ hybridization or metaphase … Monitoring a TFR attempt
in a patient with an atypical … , an EUTOS long-term survival low-risk status was predictive …

… patients with good performance status and organ functions, … Fluorescence in situ hybridization
studies may have a false … imatinib to achieve treatment-free remission (TFR) in patients …

… patients with good performance status and organ functions, … ABL1 abnormalities by
fluorescence in situ hybridization (FISH… the achievement of molecular remissions with a lower …

… reliably measures the major breakpoint region and the presence of the fusion BCR-ABL1
gene and increases the sensitivity when compared to fluorescence in situ hybridization [58,59]. …

… to optimize post-remission monitoring and to define effective … as acute lymphoblastic or
chronic myeloid leukemia [64,65], … cytometry and fluorescence in situ hybridization examination …

… lymphoblastic leukaemias (ALL), chronic myeloid leukaemia (… karyotyping and fluorescence
in-situ hybridisation (FISH) for … of TKI therapy, termed treatment-free remission (TFR), in the …

… In the 1990s, fluorescence in situ hybridization (FISH) techniques … The deletion status was
found to be an independent … -free remission due to lack of standardized monitoring; however, …

… of remission, and the possibility of attaining treatment-free … centres nowadays routinely use
fluorescence in situ hybridisation (FISH) to … call rate with appropriate control samples (which is …

… Cytogenetic analysis was performed by conventional fluorescence in situ hybridization (…
prognostic variables, including age, disease status (CR1 vs second complete remission [CR2]), …